363 related articles for article (PubMed ID: 38818970)
1. Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies.
Lukácsi S; Munkácsy G; Győrffy B
Integr Cancer Ther; 2024; 23():15347354241242094. PubMed ID: 38818970
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial immunotherapy and nanoparticle mediated hyperthermia.
Moy AJ; Tunnell JW
Adv Drug Deliv Rev; 2017 May; 114():175-183. PubMed ID: 28625829
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy.
Lee S; Son B; Park G; Kim H; Kang H; Jeon J; Youn H; Youn B
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227629
[TBL] [Abstract][Full Text] [Related]
4. Emerging hyperthermia applications for pediatric oncology.
Tydings C; Sharma KV; Kim A; Yarmolenko PS
Adv Drug Deliv Rev; 2020; 163-164():157-167. PubMed ID: 33203538
[TBL] [Abstract][Full Text] [Related]
5. A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy.
van Rhoon GC; Franckena M; Ten Hagen TLM
Adv Drug Deliv Rev; 2020; 163-164():145-156. PubMed ID: 32247801
[TBL] [Abstract][Full Text] [Related]
6. Basic principles in hyperthermic tumor therapy.
Dietzel F
Recent Results Cancer Res; 1983; 86():177-90. PubMed ID: 6647999
[TBL] [Abstract][Full Text] [Related]
7. Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery.
Partanen A; Yarmolenko PS; Viitala A; Appanaboyina S; Haemmerich D; Ranjan A; Jacobs G; Woods D; Enholm J; Wood BJ; Dreher MR
Int J Hyperthermia; 2012; 28(4):320-36. PubMed ID: 22621734
[TBL] [Abstract][Full Text] [Related]
8. Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles.
Yu Q; Tang X; Zhao W; Qiu Y; He J; Wan D; Li J; Wang X; He X; Liu Y; Li M; Zhang Z; He Q
Acta Biomater; 2021 Oct; 133():244-256. PubMed ID: 34000465
[TBL] [Abstract][Full Text] [Related]
9. Local tumour hyperthermia as immunotherapy for metastatic cancer.
Toraya-Brown S; Fiering S
Int J Hyperthermia; 2014 Dec; 30(8):531-9. PubMed ID: 25430985
[TBL] [Abstract][Full Text] [Related]
10. Influence of hyperthermia on efficacy and uptake of carbon nanohorn-cisplatin conjugates.
DeWitt MR; Pekkanen AM; Robertson J; Rylander CG; Nichole Rylander M
J Biomech Eng; 2014 Feb; 136(2):021003. PubMed ID: 24763615
[TBL] [Abstract][Full Text] [Related]
11. Nano-therapeutic cancer immunotherapy using hyperthermia-induced heat shock proteins: insights from mathematical modeling.
Lin FC; Hsu CH; Lin YY
Int J Nanomedicine; 2018; 13():3529-3539. PubMed ID: 29950833
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens.
De Sanctis F; Sandri S; Martini M; Mazzocco M; Fiore A; Trovato R; Garetto S; Brusa D; Ugel S; Sartoris S
Vaccine; 2018 Jun; 36(25):3708-3716. PubMed ID: 29752021
[TBL] [Abstract][Full Text] [Related]
13. The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors.
Cheng Y; Weng S; Yu L; Zhu N; Yang M; Yuan Y
Integr Cancer Ther; 2019; 18():1534735419876345. PubMed ID: 31522574
[TBL] [Abstract][Full Text] [Related]
14. Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours.
Centelles MN; Wright M; So PW; Amrahli M; Xu XY; Stebbing J; Miller AD; Gedroyc W; Thanou M
J Control Release; 2018 Jun; 280():87-98. PubMed ID: 29723616
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermia as an immunotherapy strategy for cancer.
Skitzki JJ; Repasky EA; Evans SS
Curr Opin Investig Drugs; 2009 Jun; 10(6):550-8. PubMed ID: 19513944
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy.
Liu X; Zhang Y; Wang Y; Zhu W; Li G; Ma X; Zhang Y; Chen S; Tiwari S; Shi K; Zhang S; Fan HM; Zhao YX; Liang XJ
Theranostics; 2020; 10(8):3793-3815. PubMed ID: 32206123
[TBL] [Abstract][Full Text] [Related]
17. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia.
Ryu S; Brown SL; Kim SH; Khil MS; Kim JH
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):133-8. PubMed ID: 12118542
[TBL] [Abstract][Full Text] [Related]
18. Targeted near infrared hyperthermia combined with immune stimulation for optimized therapeutic efficacy in thyroid cancer treatment.
Zhou L; Zhang M; Fu Q; Li J; Sun H
Oncotarget; 2016 Feb; 7(6):6878-90. PubMed ID: 26769848
[TBL] [Abstract][Full Text] [Related]
19. The biologic rationale of hyperthermia.
Hildebrandt B; Wust P
Cancer Treat Res; 2007; 134():171-84. PubMed ID: 17633053
[TBL] [Abstract][Full Text] [Related]
20. Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer.
Dunne M; Dou YN; Drake DM; Spence T; Gontijo SML; Wells PG; Allen C
J Control Release; 2018 Jul; 282():35-45. PubMed ID: 29673642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
